Thomson Medical Group (SGX:A50) Stock Flat As Losses Deepen

Thomson Medical Group stock barely moved into these results, flat over the past week and only slightly higher over the past month, yet the latest numbers tell a more uncomfortable story. For a healthcare operator often framed as a long term recovery play, the headline this time is the deepening loss. Full year revenue came in at about S$426.6m on a trailing basis, but the group still reported a net loss of about S$29.7m and stayed unprofitable from continuing operations. The market is treating this as business as usual; the income statement is not.

Looking for healthcare stocks that combine solid revenue bases with cleaner bottom lines and less earnings pressure than Thomson Medical Group right now? Benchmark Thomson Medical Group against our curated list of 297 resilient stocks with low risk scores.

FY 2026 Earnings Summary

• Total Revenue (FY 2026 vs FY 2025 TTM): S$426.6m vs. S$455.5m (revenue lower year on year)
• Net Loss (Excl. Extra Items, FY 2026 vs FY 2025 TTM): S$29.7m loss vs. S$47.6m loss (loss narrowed year on year)
• Basic EPS (FY 2026 vs FY 2025 TTM): S$0.0018 loss per share vs. S$0.0018 loss per share (EPS loss broadly unchanged)
• Loss from Continuing Operations (FY 2026 vs FY 2025 TTM): S$27.8m loss vs. S$47.0m loss (continuing operations loss narrowed year on year)

Tired of scrolling through dense earnings tables and long paragraphs about Thomson Medical Group? Get a clear visual snapshot of the company’s recent loss profile and wider financial picture in the company report for Thomson Medical Group.

Thomson Medical: Bull Case Meets Mixed Signals

For investors leaning toward the defensive healthcare story, Thomson Medical Group offers a mixed read. Group revenue of about S$426.6m on a trailing basis and a narrower loss from continuing operations of S$27.8m compared with S$47.0m point to some easing in earnings pressure. The recent half year result also showed higher revenue intensity in Singapore and contributions from Malaysia and Vietnam, which fits the regional platform narrative. The share price being broadly flat over the past week suggests the market is not treating these numbers as a clear positive shift yet.

Thomson Medical: Bear Concerns Still Have Traction

The bearish angle around profitability and execution risk still has support in the latest figures. Thomson Medical Group remains loss making, with a full year net loss of about S$29.7m and a continued loss from operations. The second half loss of S$19.5m relied partly on lower goodwill impairment and finance costs, which do not directly address underlying operating efficiency. Management also flagged an expectation of continued losses over the next 12 months as expansion and transformation continue, which keeps margin and scalability concerns very much in play.

Review whether Thomson Medical Group’s ongoing losses and weak debt coverage are early signals of deeper issues. Scan the risk analysis for Thomson Medical Group which shows 1 important warning sign.

Stay Ahead Of Your Next Move

If Thomson Medical Group’s ongoing losses and flat share price have your attention, register for free with Simply Wall St and add it to a Watchlist to track price against fair value and watch for a potential entry point. Once you own any stocks, keep control of your positions with the Portfolio Command Center that cuts through noise and focuses on key developments that matter to your holdings. For longer term investors, use the Community to see how other investors are thinking about opportunities and risks across the market. That way you can spot potential catalysts or warning signs early and stay ahead of the next move.

Seeking Fresh Alternatives Beyond Thomson Medical?

Markets move fast and the stocks with real breakout potential can gain momentum before most investors even notice. Scan these fresh ideas while they are still under the radar for now and get in early.

• Spot companies building strong cash engines before momentum really starts to fly by reviewing the carefully filtered 276 high quality undervalued stocks that still look overlooked by much of the market.
• Ride structural shifts in energy and infrastructure by assessing the hand picked 92 nuclear energy infrastructure stocks that could benefit if demand for reliable power supply keeps climbing.
• Catch quality miners before any renewed metal price buzz gets fully priced in by checking the curated 10 top silver producer stocks that currently remain off many radars.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com